Gerhard Boerner

Title: Gerhard Boerner: Innovator in Cyclosporine Formulations

Introduction

Gerhard Boerner is a notable inventor based in Utting, Germany. He has made significant contributions to the field of medicine, particularly in the development of formulations for cyclosporine. With a total of three patents to his name, Boerner's work focuses on improving treatment options for patients with specific medical conditions.

Latest Patents

Boerner's latest patents include innovative formulations of cyclosporine A (CsA) aimed at treating bronchiolitis obliterans syndrome (BOS). These formulations are designed for use in double lung transplanted patients, providing a method for prevention and treatment of BOS. The compositions are administered through inhalation in aerosolized form, ensuring that patients receive a therapeutically effective dose of cyclosporine A.

Career Highlights

Throughout his career, Gerhard Boerner has worked with various companies, including Breath Therapeutics GmbH. His expertise in pharmaceutical formulations has positioned him as a key player in the development of treatments for complex medical conditions. His innovative approach has led to advancements that benefit patients undergoing lung transplants.

Collaborations

Boerner has collaborated with notable professionals in his field, including Oliver Denk and Aldo T. Iacono. These partnerships have contributed to the success of his projects and the advancement of medical treatments.

Conclusion

Gerhard Boerner's contributions to the field of medicine through his innovative cyclosporine formulations highlight his dedication to improving patient care. His work continues to influence the treatment of bronchiolitis obliterans syndrome, showcasing the importance of innovation in healthcare.